Representing Fearless andUndaunted Innovators.
The unique history of Wilson Sonsini Goodrich & Rosati closely traces the birth and evolution of Silicon Valley.
For more than 60 years, Wilson Sonsini has represented technology pioneers associated with virtually every milestone innovation, as well as life sciences trailblazers shaping the future of healthcare.
Today, the firm is synonymous with ushering promising, innovative companies through their business life cycle.
Careers
We look for the best and brightest of tomorrow and develop careers from the ground up.
News and Featured Insights
Leading Matters
Client Highlights
Wilson Sonsini Advises Beren Therapeutics P.B.C. on $300 Million Financing, Including Equity and Debt and Royalty Facilities
On June 10, 2026, Beren Therapeutics P.B.C., a leader in cholesterol trafficking biology and cyclodextrin-based therapeutics, announced it has secured $300 million in combined financing. The financing consists of:
Client Highlights
Wilson Sonsini Advises Adyen on $335 Million Acquisition of Orb
On June 11, 2026, Adyen, a financial technology platform, announced it has entered into a definitive agreement to acquire enterprise billing platform Orb through a reverse triangular merger. Wilson Sonsini Goodrich & Rosati is advising Adyen on the transaction.
Client Highlights
Wilson Sonsini Advises Maneva on $27 Million Series A
On June 10, 2026, Maneva, the video-to-action AI company building the intelligence layer for modern manufacturing, announced $27 million in Series A funding, accelerating its mission to close the $18 trillion global manufacturing efficiency gap. The Series A round was led by U.S. Venture Partners (USVP), with participation from returning investors Bling Capital and Freestyle Capital, alongside a group of leading angel investors and funds. This fundraise brings Maneva’s total capital raised to $38.4 million. Wilson Sonsini Goodrich & Rosati advised Maneva on the transaction.
The proceeds from the Series A will position Maneva to accelerate on three fronts: deepening its core AI capabilities through continued development of its patent-pending VITA and ALIS agents, expanding its customer base into new geographies and industries, and rolling out its next generation of factory orchestration and AI knowledge agent features.
The Wilson Sonsini team that advised Maneva on the transaction included Rezwan Pavri, Lester Ang, Karin Hjorth, and Keili Prenton.
For more information, please see Maneva’s news release.
The proceeds from the Series A will position Maneva to accelerate on three fronts: deepening its core AI capabilities through continued development of its patent-pending VITA and ALIS agents, expanding its customer base into new geographies and industries, and rolling out its next generation of factory orchestration and AI knowledge agent features.
The Wilson Sonsini team that advised Maneva on the transaction included Rezwan Pavri, Lester Ang, Karin Hjorth, and Keili Prenton.
For more information, please see Maneva’s news release.
Client Highlights
Wilson Sonsini Advises SonoThera on Patent Matters Related to Oversubscribed $125 Million Series B
On June 10, 2026, SonoThera, a biotechnology company developing next-generation genetic medicines to address the root causes of disease, announced the closing of an oversubscribed $125 million Series B financing round to advance its lead programs in Duchenne muscular dystrophy (DMD) and autosomal dominant polycystic kidney disease (ADPKD) into the clinic and expand its pipeline of targeted, redosable genetic medicines. Wilson Sonsini Goodrich & Rosati advised SonoThera on patent matters related to the transaction.
Client Highlights
Wilson Sonsini Advises Kiavi on $717 Million Acquisition by Figure
On June 10, 2026, Figure Technology Solutions (Figure), the blockchain-native capital marketplace for the origination, funding, sale, and trading of tokenized assets, announced a definitive agreement to acquire Kiavi, an AI-powered lending platform for residential real estate investors. The transaction includes the purchase of Kiavi’s balance sheet assets by a joint venture between Figure and Sixth Street, a leading global investment firm, who is buying loans off Kiavi’s balance sheet. The total transaction purchase price is $717 million. Wilson Sonsini Goodrich & Rosati is advising Kiavi on the transaction.
Client Highlights
Wilson Sonsini Advises SewerAI on Strategic Investment
On June 2, 2026, SewerAI, a leading AI platform for sewer and underground infrastructure intelligence, announced a major strategic investment led by JMI Equity, a leading growth equity software investor based in the greater Washington, D.C., area and San Diego, with continued participation from Innovius Capital, Epic Ventures, and Bentley Systems. Wilson Sonsini Goodrich & Rosati advised SewerAI on the transaction.
The Life Sciences Report – June 2026
This latest edition features articles on accelerating new therapies under the new FDA administration, cash-pay healthcare companies possibly facing kickback and fee-splitting risk under federal and state laws, building in-house legal teams for biotech, digital health, and medical devices companies, and life sciences venture financings for firm clients across 1H2025.